Investigating racial and geographic differences in Alzheimer's disease risk and survival
Racial and Geographic Disparities in Risk and Survival of Alzheimer's Disease and Related Dementias
['FUNDING_R01'] · DUKE UNIVERSITY · NIH-10631111
This study looks at how race and where you live can change the chances of getting Alzheimer's disease and how long people live with it, aiming to uncover important differences among various groups and help improve care for everyone affected.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | DUKE UNIVERSITY (nih funded) |
| Locations | 1 site (DURHAM, UNITED STATES) |
| Trial ID | NIH-10631111 on ClinicalTrials.gov |
What this research studies
This research examines how race and geographic location affect the risk and survival rates of Alzheimer's disease and related dementias. By analyzing data from various sources, including Medicare and death records, the study aims to identify significant disparities in incidence and mortality rates among different racial groups and regions. It also explores the impact of behavioral factors, comorbidities, and genetic influences on these disparities. The goal is to provide a detailed understanding of the factors contributing to health inequities in Alzheimer's disease.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals from diverse racial backgrounds who are at risk for Alzheimer's disease or related dementias.
Not a fit: Patients who do not have Alzheimer's disease or related dementias, or those from homogeneous racial backgrounds may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to targeted interventions that reduce disparities in Alzheimer's disease outcomes among different racial and geographic populations.
How similar studies have performed: Previous studies have indicated significant disparities in Alzheimer's disease outcomes based on race and geography, suggesting that this research builds on established findings rather than exploring entirely novel territory.
Where this research is happening
DURHAM, UNITED STATES
- DUKE UNIVERSITY — DURHAM, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: AKUSHEVICH, IGOR — DUKE UNIVERSITY
- Study coordinator: AKUSHEVICH, IGOR
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.